How many drugs treat Lack or loss of sexual desire?

Drug Landscape tracks 2 marketed treatments for Lack or loss of sexual desire (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/lack-or-loss-of-sexual-desire.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-11 · How we verify

Lack or loss of sexual desire — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Lack or loss of sexual desire (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Lack or loss of sexual desire, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Vyleesi (Autoinjector)	BREMELANOTIDE	Cosette	Melanocortin Receptor Agonist	MC1R, MC4R		2019-01-01
Addyi	FLIBANSERIN	Sprout Pharms		5-hydroxytryptamine receptor 1A		2015-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Cosette · 1 drug in Lack or loss of sexual desire
Sprout Pharms · 1 drug in Lack or loss of sexual desire

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Lack or loss of sexual desire:

Cite this brief

Drug Landscape (2026). Lack or loss of sexual desire — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/lack-or-loss-of-sexual-desire. Accessed 2026-06-11.

Lack or loss of sexual desire full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing